Ubiquigent joins Imperial College London for DUB probe discovery
The project will expand on Ubiquigent’s DUB-based drug discovery platform and recent developments in activity-based probes.
The project will expand on Ubiquigent’s DUB-based drug discovery platform and recent developments in activity-based probes.
